Transjugular Transcatheter Tricuspid Valve Replacement in Patients With Cardiac Implantable Electronic Devices.

ABSTRACT:

Background

Cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is common. Transcatheter tricuspid valve replacement (TTVR) is feasible with CIEDs in the right ventricle; however, data in this population are limited.

Objectives

This study retrospectively analyzed patients undergoing compassionate-use transjugular TTVR with the LuX-Valve Plus for symptomatic TR with CIEDs from January 2022 to August 2024 at 17 international centers.

Methods

The primary endpoint was procedural TR reduction. Secondary endpoints included TR reduction, survival at 30 days, NYHA functional class changes, and CIED function at follow-up. Non-CIED group was used for comparison.

Results

Of 99 patients, 36 (36.4%) had CIEDs. Baseline characteristics were simil

SUBMITTER: So KC 

PROVIDER: S-EPMC12790058 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature